| Symbol |
Name |
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANXA4
|
annexin A4
|
|
APC
|
adenomatous polyposis coli
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
E2F1
|
E2F transcription factor 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
FDXR
|
ferredoxin reductase
|
|
FHIT
|
fragile histidine triad
|
|
GATA6
|
GATA binding protein 6
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR143
|
microRNA 143
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog
|
|
NBAS
|
neuroblastoma amplified sequence
|
|
NIT1
|
nitrilase 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PROM1
|
prominin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
TENM4
|
teneurin transmembrane protein 4
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TP53
|
tumor protein p53
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WWOX
|
WW domain containing oxidoreductase
|